Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

IMPROVE focuses on improving deep learning models to predict the efficacy of cancer treatments. The research community, including data scientists and informaticists, is asked to respond to an RFI for creating protocols to evaluate model performance by April 15, 2022, at 5:00 p.m. ET. Additionally, they are encouraged to respond to an RFP for improving model comparison by May 9, 2022.

In RAS-related diseases, such as cancer, mutations in the RAS genes or their regulators render RAS proteins persistently active. Investigating RAS activation events is challenging when using conventional techniques. An unprecedented multiscale platform is using machine learning to change that.

The relaunched monthly CWIG webinar series will invite researchers from across the globe to discuss the latest advancements in cloud computing technologies, workflow, tools, and packages.

Data scientists, cancer biologists, and computational scientists are invited to submit abstracts to the Computational Approaches for Cancer Workshop (CAFCW21). Papers should focus on the application of computational approaches to cancer challenges, and those selected will be presented at the workshop. Abstract submissions are due by Monday, September 13.

Attending the second week of the 2021 American Association for Cancer Research (AACR) Annual Meeting? Here are a few event sessions you won’t want to miss to learn more about the latest NCI data science, data commons, and cancer research activities.

NCI Director, Dr. Ned Sharpless, will serve as keynote speaker at the Sixth Computational Approaches for Cancer Workshop (CAFCW20), which will be held virtually on November 13, 2020. The CAFCW20 workshop will bring together clinicians, cancer biologists, mathematicians, data scientists, computational scientists, engineers, developers, and thought leaders interested in advancing computational approaches to better understand cancer. Abstracts may be submitted for this workshop, but they must be submitted no later than Tuesday, September 8.